Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced
Latest available record · 8 Oct 2026

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 17 Aug 2025
Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.
714not yet publishedAug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26

Scope · likely financings by canton

28 likely financings · 1 Aug 2025 – 17 Aug 2025 · the feed below shows one weekClick a canton to filter the feedMap: Natural Earth

Likely financing
Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided
Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased
No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round
A financing announcement on startupticker.ch names the company and matches this increase.

Published 11–17 Aug 2025

42 capital increases · 13 shown
Showing: likely financings and confirmed rounds ▾
Show
Capital increases published 11–17 Aug 2025
CompanyStatusNominal share capital (CHF)
before → after		New shares, % of
post-step shares		Announced roundnot disclosed in the SHABSHAB publishedSource
Comphya SAVD · la société a pour but le développement d'implants pour le traitement du dysfonctionnement érectile (pour but …SHAB publication HR02-1006410003Confirmed roundscore 0.75Announced round: CHF 7’500’000 ↗198’601.48 → 224’424.78New shares — no new shares— no new sharesCHF 7’500’000 ↗15 Aug 2025SHAB publication HR02-1006410003
Berlin Heals Holding AGZG · Forschung und Entwicklung von medizintechnischen Produkten sowie Erwerb und Halten von Beteiligungen sowie …SHAB publication HR02-1006409588Likely financingscore 0.62144’821 → 150’894New shares 4.0%4.0%—15 Aug 2025SHAB publication HR02-1006409588
LiveMap AGLU · Die Gesellschaft bezweckt die Entwicklung von Software, elektronischen Plattformen, Informationstechnologien …SHAB publication HR02-1006409515Likely financingscore 0.95100’000 → 181’818New shares 45.0%45.0%—15 Aug 2025SHAB publication HR02-1006409515
OnconiX AGBE · Die Gesellschaft betreibt angewandte medizinische Forschung und Entwicklung, insbesondere die Entwicklung von …SHAB publication HR02-1006409437Likely financingscore 0.68100’000 → 110’000New shares 9.1%9.1%—15 Aug 2025SHAB publication HR02-1006409437
Viatu AGZG · Die Gesellschaft bezweckt den Betrieb einer Technologie- und Marketingplattform im Zusammenhang mit …SHAB publication HR02-1006408565Likely financingscore 0.75146’249.72 → 157’568.83New shares 7.2%7.2%—14 Aug 2025SHAB publication HR02-1006408565
Artificialy SATI · La prestazione di consulenza in ambito tecnologico e lo sviluppo di soluzioni tecnologiche, in particolare …SHAB publication HR02-1006407859Likely financingscore 0.621’141’240 → 1’341’240New shares 14.9%14.9%—13 Aug 2025SHAB publication HR02-1006407859
Hygentile AGAG · Die Gesellschaft bezweckt die Erfindung, die Entwicklung, die Produktion, den Handel, die Vermarktung und den …SHAB publication HR02-1006407825Likely financingscore 0.60171’000 → 187’757New shares 8.9%8.9%—13 Aug 2025SHAB publication HR02-1006407825
Ens Dynamics AGZG · Die Gesellschaft bezweckt den Handel, die Entwicklung, die Produktion, den Betrieb und die Reparatur von …SHAB publication HR02-1006407555Likely financingscore 0.85125’559.95 → 135’743.25New shares 7.5%7.5%—13 Aug 2025SHAB publication HR02-1006407555
Backed Finance AGZG · Der Zweck des Unternehmens ist die Konvergenz von Blockchain-Technologien und konventionellen Finanzmärkten …SHAB publication HR02-1006407544Likely financingscore 0.68188’183.67 → 199’595.70New shares 5.7%5.7%—13 Aug 2025SHAB publication HR02-1006407544
Wintergreen Switzerland SAGE · d'exploiter une plateforme de type place de marché pour les voyages et les produits et services connexes …SHAB publication HR02-1006407140Likely financingscore 0.75GBP 240’411.11 → 252’674.07New shares 2.9%2.9%—12 Aug 2025SHAB publication HR02-1006407140
Cellula Therapeutics SAVD · la société a pour but notamment la recherche, la fabrication, le développement et la commercialisation de …SHAB publication HR02-1006406935Likely financingscore 0.72134’000 → 180’660New shares — share counts not published— share counts not published—12 Aug 2025SHAB publication HR02-1006406935
Embion Technologies SAVD · la société a pour but toutes activités de recherche, de développement et de commercialisation dans les …SHAB publication HR02-1006405845Likely financingscore 0.90341’339.90 → 495’496.90New shares 31.1%31.1%—11 Aug 2025SHAB publication HR02-1006405845
Aseptuva AGBE · Die Gesellschaft bezweckt die Entwicklung von Desinfektions-Technologie. Die Gesellschaft kann …SHAB publication HR02-1006405171Likely financingscore 0.80100’000 → 131’625.50New shares 24.0%24.0%—11 Aug 2025SHAB publication HR02-1006405171

29 other capital increases published this week ▸